Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial-Reference-Cited by-同舟云学术

Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial

Published:2018-08 Issue:2 Volume:79 Page:277-286.e10
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Papp Kim A.,Merola Joseph F.,Gottlieb Alice B.,Griffiths Christopher E.M.,Cross Nancy,Peterson Luke,Cioffi Christopher,Blauvelt Andrew

Publisher

Elsevier BV

Subject

Dermatology

Reference34 articles.

1. Global epidemiology of psoriasis: a systematic review of incidence and prevalence;Parisi;J Invest Dermatol,2013

2. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study;Yeung;JAMA Dermatol,2013

3. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries;Dalgard;J Invest Dermatol,2015

4. The psychosocial burden of psoriasis;Kimball;Am J Clin Dermatol,2005

5. Pathogenesis and therapy of psoriasis;Lowes;Nature,2007

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A transdermal delivery system using microneedle patches containing poly(lactic-co-glycolic)-encapsulated acitretin nanoparticles for topical and extended treatment;International Biodeterioration & Biodegradation;2024-11

2. Quality of reporting and concordance between sources of adverse events in the treatment of moderate-to-severe psoriasis: a cross-sectional study of RCTs from a Cochrane systematic review;Journal of Clinical Epidemiology;2024-09

3. IL-17A enhances the inflammatory response of glaucoma through Act1/TRAF6/NF-κB pathway;Neurochemistry International;2024-09

4. Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of phase 2/3 randomized trials;Journal of the American Academy of Dermatology;2024-07

5. Performance of two large language models for data extraction in evidence synthesis;Research Synthesis Methods;2024-06-19